speb/financial-data huggingface dataset:
Financial ratios for AMTB — quarterly report dated 2025-06-30
Total revenue: 109144000
Net income: 23002000
Capital expenditures: 1340000
Operating cash flow: 57590000
Depreciation & amortization: 1551000
Net tangible assets: 905093000
Owner earnings: 23213000
Return on net tangible assets (%): 2.5647088199776156
Buffett classification: The Gruesome
Stock price: 17.91
P/E ratio: 19.707378132151028
Shares outstanding: 38468450
Book value: 924286000
P/B ratio: 0.7454077412186272
Market cap (USD): 688969939.5
Debt to equity: 1.0474182233637641
Effective tax rate (%): 22.80430915864013
COGS to revenue (%): 0
SG&A to revenue (%): 40.08557502015685
Free cash flow (dilution-adjusted): 54625000
Buyback yield (%): 0.7937937036801589
Retained earnings: 609540000
Capitalized R&D asset: 0
FCF margin (%): 50.04855970094554
Revenue growth (%): 3.878403715653523
Rule of 40 score: 53.926963416599065
Financial ratios for AMTB — quarterly report dated 2025-09-30
Total revenue: 108728000
Net income: 14756000
Capital expenditures: 1017000
Operating cash flow: 22698000
Depreciation & amortization: 1487000
Net tangible assets: 925747000
Owner earnings: 15226000
Return on net tangible assets (%): 1.6447258268187746
Buffett classification: The Gruesome
Stock price: 19.02
P/E ratio: 14.716990888245233
Shares outstanding: 38468450
Book value: 944940000
P/B ratio: 0.7743030446377548
Market cap (USD): 731669919
Debt to equity: 1.095683323808919
Effective tax rate (%): 22.36952861952862
COGS to revenue (%): 0
SG&A to revenue (%): 38.28820543006402
Free cash flow (dilution-adjusted): 22563000
Buyback yield (%): 1.3026365786673813
Retained earnings: 620542000
Capitalized R&D asset: 0
FCF margin (%): 20.751784269001543
Revenue growth (%): -0.3811478413838598
Rule of 40 score: 20.370636427617683
Financial ratios for AMTB — annual report dated 2025-12-31
Total revenue: 419329000
Net income: 52417000
Capital expenditures: 6368000
Operating cash flow: 136980000
Depreciation & amortization: 6686000
Net tangible assets: 919609000
Owner earnings: 52735000
Return on net tangible assets (%): 5.734502380903188
Buffett classification: The Gruesome
Stock price: 19.35
P/E ratio: 14.200822395406073
Shares outstanding: 38468450
Book value: 938802000
P/B ratio: 0.7928876456377384
Market cap (USD): 744364507.5
Debt to equity: 0.983607832109433
Effective tax rate (%): 20.749610680213486
COGS to revenue (%): 0
SG&A to revenue (%): 40.694538178852405
Free cash flow (dilution-adjusted): 124256000
Buyback yield (%): 4.433311860990363
Retained earnings: 619552000
Capitalized R&D asset: 0
FCF margin (%): 29.632102716482763
Revenue growth (%): 37.35296911491584
Rule of 40 score: 66.9850718313986
Financial ratios for AMTB — quarterly report dated 2025-12-31
Total revenue: 96388000
Net income: 2701000
Capital expenditures: 8902000
Operating cash flow: 36482000
Depreciation & amortization: 2060000
Net tangible assets: 919609000
Owner earnings: -4141000
Return on net tangible assets (%): -0.4503000731832768
Buffett classification: The Gruesome
Stock price: 19.35
P/E ratio: 14.200822395406073
Shares outstanding: 38468450
Book value: 938802000
P/B ratio: 0.7928876456377384
Market cap (USD): 744364507.5
Debt to equity: 0.983607832109433
Effective tax rate (%): -41.63607760880964
COGS to revenue (%): 0
SG&A to revenue (%): 46.73299580860688
Free cash flow (dilution-adjusted): 29859000
Buyback yield (%): 1.7464561876628704
Retained earnings: 619552000
Capitalized R&D asset: 0
FCF margin (%): 30.977922562974648
Revenue growth (%): -11.349422411890222
Rule of 40 score: 19.628500151084424
Financial ratios for CELH — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 549689
Buffett classification: The Gruesome
Stock price: 24.86
Shares outstanding: 255640360
Market cap (USD): 6355219349.599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELH — annual report dated 2022-12-31
Total revenue: 653604000
Gross profit: 270869000
Operating income: -157801000
Net income: -187282000
Capital expenditures: 8264000
Operating cash flow: 108182000
Depreciation & amortization: 1917000
Net tangible assets: 838646000
Owner earnings: -193629000
Return on net tangible assets (%): -23.088287549216236
Buffett classification: The Gruesome
Stock price: 34.68
Shares outstanding: 255640360
Book value: 864579000
P/B ratio: 10.254248235036938
Market cap (USD): 8865607684.8
Debt to equity: 0.001409934777504427
Current ratio: 5.691255153600546
Quick ratio: 4.6168945100592085
COGS to revenue (%): 58.557628166290286
SG&A to revenue (%): 65.5855839315549
Free cash flow (dilution-adjusted): 79253000
Buyback yield (%): 0
Retained earnings: -238772000
Inventory turnover: 2.2086514435422906
Receivables turnover: 9.859767687434003
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.876024487779677
FCF margin (%): 12.125537787406442
Rule of 40 score: 12.125537787406442
Financial ratios for CELH — annual report dated 2023-12-31
Total revenue: 1318014000
Gross profit: 633139000
Operating income: 266366000
Net income: 226801000
Capital expenditures: 17433000
Operating cash flow: 141218000
Depreciation & amortization: 3226000
Net tangible assets: 1062216000
Owner earnings: 212594000
Return on net tangible assets (%): 20.01419673588046
Capex to operating income (%): 6.5447542103721945
Buffett classification: The Great
Stock price: 54.52
P/E ratio: 61.45260570808771
Shares outstanding: 255640360
Book value: 1088528000
P/B ratio: 12.803999922096631
Market cap (USD): 13937512427.2
Debt to equity: 0.0020091352725883026
Current ratio: 4.355919642243857
Quick ratio: 3.527054043013163
Effective tax rate (%): 22.261601582181946
COGS to revenue (%): 51.96264986563117
SG&A to revenue (%): 27.827701374947463
Free cash flow (dilution-adjusted): 102559000
Buyback yield (%): 0
Retained earnings: -12053000
Inventory turnover: 2.987133355141206
Receivables turnover: 7.085296821326624
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.143800162408922
FCF margin (%): 7.781328574658539
Revenue growth (%): 101.65329465547946
Rule of 40 score: 109.434623230138
Financial ratios for CELH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.36
Shares outstanding: 255640360
Market cap (USD): 8016881689.599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELH — annual report dated 2024-12-31
Total revenue: 1355630000
Gross profit: 680207000
Operating income: 155728000
Net income: 145074000
Capital expenditures: 23390000
Operating cash flow: 262898000
Depreciation & amortization: 7274000
Net tangible assets: 1140622000
Owner earnings: 128958000
Return on net tangible assets (%): 11.305936585477047
Capex to operating income (%): 15.019778074591594
Buffett classification: The Great
Stock price: 26.34
P/E ratio: 46.414706166508125
Shares outstanding: 255640360
Book value: 1224417000
P/B ratio: 5.499406723689724
Market cap (USD): 6733567082.4
Debt to equity: 0.016538483212827002
Current ratio: 3.6236748874936735
Quick ratio: 3.264844679716033
Effective tax rate (%): 25.622148167136633
COGS to revenue (%): 49.82355067385644
SG&A to revenue (%): 38.68894904951941
Free cash flow (dilution-adjusted): 219917000
Buyback yield (%): 0.03357804225207373
Retained earnings: 105521000
Inventory turnover: 5.1494148591468765
Receivables turnover: 5.01450015165975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.1127444613964
FCF margin (%): 16.222494338425676
Revenue growth (%): 2.8539909287761738
Rule of 40 score: 19.07648526720185
Financial ratios for CELH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.34
Shares outstanding: 255640360
Market cap (USD): 6733567082.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELH — quarterly report dated 2025-03-31
Total revenue: 329276000
Gross profit: 172373000
Operating income: 52031000
Net income: 44419000
Capital expenditures: 6944000
Operating cash flow: 103367000
Depreciation & amortization: 2611000
Net tangible assets: 1183030000
Owner earnings: 40086000
Return on net tangible assets (%): 3.388417876131628
Capex to operating income (%): 13.345889950221984
Buffett classification: The Great
Stock price: 35.62
P/E ratio: 51.25008230261824
Shares outstanding: 255640360
Book value: 1267602000
P/B ratio: 7.183571517873906
Market cap (USD): 9105909623.199999
Debt to equity: 0.015542733444724764
Current ratio: 3.3778688249962907
Quick ratio: 3.040049873879393
Effective tax rate (%): 27.17361008640336
COGS to revenue (%): 47.65090683803253
SG&A to revenue (%): 36.54745562992748
Free cash flow (dilution-adjusted): 91394000
Buyback yield (%): 0.021216990723009796
Retained earnings: 143159000
Inventory turnover: 1.1115338023080357
Receivables turnover: 1.2841075718341497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6090933809819767
FCF margin (%): 27.75604659920553
Rule of 40 score: 27.75604659920553
Financial ratios for CELH — quarterly report dated 2025-06-30
Total revenue: 739259000
Gross profit: 380851000
Operating income: 142965000
Net income: 99855000
Capital expenditures: 8250000
Operating cash flow: 43712000
Depreciation & amortization: 9119000
Net tangible assets: 66965000
Owner earnings: 100724000
Return on net tangible assets (%): 150.41290226237587
Capex to operating income (%): 5.7706431644108696
Buffett classification: The Great
Stock price: 46.39
P/E ratio: 82.19884594868098
Shares outstanding: 255640360
Book value: 2091314000
P/B ratio: 5.670672266527169
Market cap (USD): 11859156300.4
Debt to equity: 0.4126195301136032
Current ratio: 2.108615815997878
Quick ratio: 1.7599424046076313
Effective tax rate (%): 22.871046228710462
Interest coverage ratio: 7.907356194690266
COGS to revenue (%): 48.48206109090319
SG&A to revenue (%): 32.178979221084894
Free cash flow (dilution-adjusted): 29028000
Buyback yield (%): 0.007411994392639484
Retained earnings: 236163000
Inventory turnover: 1.5579840553628406
Receivables turnover: 1.5074950702401564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.559751837742811
FCF margin (%): 3.926634643609344
Revenue growth (%): 124.51044108893453
Rule of 40 score: 128.43707573254386
Financial ratios for CELH — quarterly report dated 2025-09-30
Total revenue: 725106000
Gross profit: 372279000
Operating income: 166708000
Net income: -61014000
Capital expenditures: 10345000
Operating cash flow: 331801000
Depreciation & amortization: 8786000
Net tangible assets: 650609000
Owner earnings: -62573000
Return on net tangible assets (%): -9.617604429081062
Capex to operating income (%): 6.205461045660677
Buffett classification: The Great
Stock price: 57.49
P/E ratio: 176.5165060821523
Shares outstanding: 255640360
Book value: 2963385000
P/B ratio: 4.959451538156534
Market cap (USD): 14696764296.4
Debt to equity: 0.29070539265063433
Current ratio: 1.8868772036214223
Quick ratio: 1.6123220095861177
Interest coverage ratio: 9.138189990681358
COGS to revenue (%): 48.65867886902053
SG&A to revenue (%): 28.35047565459395
Free cash flow (dilution-adjusted): 314072000
Buyback yield (%): 0.003048290024694337
Retained earnings: 165480000
Inventory turnover: 1.2488832411845077
Receivables turnover: 1.4115853777239615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.934836382862214
FCF margin (%): 43.31394306487603
Revenue growth (%): -1.9144846393483204
Rule of 40 score: 41.399458425527705
Financial ratios for CELH — annual report dated 2025-12-31
Total revenue: 2515269000
Gross profit: 1267333000
Operating income: 468523000
Net income: 107999000
Capital expenditures: 36067000
Operating cash flow: 359442000
Depreciation & amortization: 29451000
Net tangible assets: 631967000
Owner earnings: 101383000
Return on net tangible assets (%): 16.04245158370611
Capex to operating income (%): 7.698021228413546
Buffett classification: The Great
Stock price: 45.74
P/E ratio: 108.26942903545404
Shares outstanding: 255640360
Book value: 2941442000
P/B ratio: 3.975257736307566
Market cap (USD): 11692990066.4
Debt to equity: 0.22775427834375112
Current ratio: 1.6789750131173253
Quick ratio: 1.3659223936384217
Effective tax rate (%): 13.62360336871066
Interest coverage ratio: 9.5661841272434
COGS to revenue (%): 49.6144149989524
SG&A to revenue (%): 31.758432199498344
Free cash flow (dilution-adjusted): 295325000
Buyback yield (%): 0.3891562358438711
Retained earnings: 175912000
Inventory turnover: 3.6954201683160695
Receivables turnover: 3.3292817065277385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.594535369020972
FCF margin (%): 11.741288903890599
Revenue growth (%): 85.54244152165413
Rule of 40 score: 97.28373042554472
Financial ratios for CELH — quarterly report dated 2025-12-31
Total revenue: 721628000
Gross profit: 341830000
Operating income: 106819000
Net income: 24739000
Capital expenditures: 10528000
Operating cash flow: -119438000
Depreciation & amortization: 8935000
Net tangible assets: 631967000
Owner earnings: 23146000
Return on net tangible assets (%): 3.6625330120085384
Capex to operating income (%): 9.855924507812281
Buffett classification: The Great
Stock price: 45.74
P/E ratio: 108.26942903545404
Shares outstanding: 255640360
Book value: 2941442000
P/B ratio: 3.975257736307566
Market cap (USD): 11692990066.4
Debt to equity: 0.22775427834375112
Current ratio: 1.6789750131173253
Quick ratio: 1.3659223936384217
Effective tax rate (%): -9.435548084579315
Interest coverage ratio: 8.441520467836257
COGS to revenue (%): 52.630718320242565
SG&A to revenue (%): 32.566779559551456
Free cash flow (dilution-adjusted): -139169000
Buyback yield (%): 0.36128483612922674
Retained earnings: 175912000
Inventory turnover: 1.1246676024139912
Receivables turnover: 0.9551673794406081
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6434490378987823
FCF margin (%): -19.28542129739977
Revenue growth (%): -0.47965400920692974
Rule of 40 score: -19.765075306606697
Financial ratios for CLRO — annual report dated 2021-12-31
Capital expenditures: 221000
Buffett classification: The Gruesome
Stock price: 7.45
Shares outstanding: 2675412
Market cap (USD): 19931819.400000002
Buyback yield (%): 0
Capitalized R&D asset: 5794000
Rule of 40 score: 0
Financial ratios for CLRO — annual report dated 2022-12-31
Total revenue: 25205000
Gross profit: 9457000
Operating income: -7222000
Net income: 20556000
Capital expenditures: 51000
Operating cash flow: -4179000
Depreciation & amortization: 3567000
Net tangible assets: 72059000
Owner earnings: 24072000
Return on net tangible assets (%): 33.40595900581468
Buffett classification: The Gruesome
Stock price: 8.77
P/E ratio: 1.141436234676007
Shares outstanding: 2675412
Book value: 74130000
P/B ratio: 0.3165164338324565
Market cap (USD): 23463363.24
Debt to equity: 0.06562795089707271
Current ratio: 9.535344827586206
Quick ratio: 8.431773399014778
Effective tax rate (%): 25.14202476329206
Interest coverage ratio: -17.195238095238096
COGS to revenue (%): 62.47966673279112
R&D to revenue (%): 17.417179131124776
SG&A to revenue (%): 48.756199166831976
Free cash flow (dilution-adjusted): -5217000
Buyback yield (%): 0
Retained earnings: -516000
Inventory turnover: 1.757393148086151
Receivables turnover: 0.4223782551865134
Capitalized R&D asset: 8271980
ROCI (R&D-adjusted, %): -7.421358431191571
FCF margin (%): -20.698274151953978
Rule of 40 score: -20.698274151953978
Financial ratios for CLRO — annual report dated 2023-12-31
Total revenue: 18704000
Gross profit: 6357000
Operating income: -6772000
Net income: -560000
Capital expenditures: 375000
Operating cash flow: 54628000
Depreciation & amortization: 1338000
Net tangible assets: 42996000
Owner earnings: 403000
Buffett classification: The Gruesome
Stock price: 11.11
Shares outstanding: 2675412
Book value: 44685000
P/B ratio: 0.6651857965760322
Market cap (USD): 29723827.32
Debt to equity: 0.023453060311066354
Current ratio: 10.156389214536928
Quick ratio: 7.665181711606096
Interest coverage ratio: -12.610800744878958
COGS to revenue (%): 66.01261762189907
R&D to revenue (%): 19.626817792985456
SG&A to revenue (%): 50.56672369546621
Free cash flow (dilution-adjusted): 54009000
Buyback yield (%): 0
Retained earnings: -1076000
Inventory turnover: 1.1620705882352942
Receivables turnover: 2.5569377990430624
Capitalized R&D asset: 8524320
ROCI (R&D-adjusted, %): -14.047073649659989
Rosenberg metric: -0.7061503416856492
FCF margin (%): 288.75641573994864
Revenue growth (%): -25.792501487800042
Rule of 40 score: 262.9639142521486
Financial ratios for CLRO — quarterly report dated 2024-09-30
Capital expenditures: 20000
Buffett classification: The Gruesome
Stock price: 9.3
Shares outstanding: 2675412
Market cap (USD): 24881331.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLRO — quarterly report dated 2024-12-31
Capital expenditures: 41000
Buffett classification: The Gruesome
Stock price: 11.7
Shares outstanding: 2675412
Market cap (USD): 31302320.4
Buyback yield (%): 0
Capitalized R&D asset: 755000
Rule of 40 score: 0
Financial ratios for CLRO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -194000
Operating income: -2135000
Net income: -8983000
Capital expenditures: 196000
Operating cash flow: -8919000
Depreciation & amortization: 240000
Net tangible assets: 21331000
Owner earnings: -8939000
Return on net tangible assets (%): -41.90614598471708
Buffett classification: The Gruesome
Stock price: 11.7
Shares outstanding: 2675412
Book value: 21331000
P/B ratio: 1.4674567718344191
Market cap (USD): 31302320.4
Debt to equity: 0.03614457831325301
Current ratio: 5.289985895627645
Quick ratio: 4.60620592383639
Free cash flow (dilution-adjusted): -9017000
Buyback yield (%): 0
Retained earnings: -10059000
Inventory turnover: 0.08003300330033003
Receivables turnover: 0
Capitalized R&D asset: 7207270
ROCI (R&D-adjusted, %): -8.682524080817217
Rosenberg metric: -1.7845273767365841
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CLRO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -27000
Operating income: -826000
Net income: -2834000
Capital expenditures: 5000
Operating cash flow: -1432000
Depreciation & amortization: 78000
Net tangible assets: 18014000
Owner earnings: -2761000
Return on net tangible assets (%): -15.326967913844788
Buffett classification: The Gruesome
Stock price: 8.4
Shares outstanding: 2675412
Book value: 19514000
P/B ratio: 1.1516583376037717
Market cap (USD): 22473460.8
Debt to equity: 0.02357281951419494
Current ratio: 4.813239436619718
Quick ratio: 2.0340845070422535
Free cash flow (dilution-adjusted): -1455000
Buyback yield (%): 0
Retained earnings: -12893000
Inventory turnover: 0.0027366713967159942
Receivables turnover: 0
Capitalized R&D asset: 505850.00000000006
ROCI (R&D-adjusted, %): -4.981160796893285
Rule of 40 score: 0
Financial ratios for CLRO — quarterly report dated 2025-06-30
Total revenue: 1916000
Gross profit: -231000
Operating income: -4559000
Net income: -4572000
Capital expenditures: 0
Operating cash flow: -1136000
Depreciation & amortization: 313000
Net tangible assets: 13493000
Owner earnings: -4259000
Return on net tangible assets (%): -31.564514933669308
Buffett classification: The Gruesome
Stock price: 5.75
Shares outstanding: 2675412
Book value: 14946000
P/B ratio: 1.029280008028904
Market cap (USD): 15383619
Debt to equity: 0.22835541281948346
Current ratio: 2.249499933324443
Quick ratio: 1.069875983464462
COGS to revenue (%): 112.05636743215031
R&D to revenue (%): 70.92901878914405
SG&A to revenue (%): 154.95824634655534
Free cash flow (dilution-adjusted): -1190000
Buyback yield (%): 0
Retained earnings: -17465000
Inventory turnover: 0.24270856884467557
Receivables turnover: 1.7707948243992606
Capitalized R&D asset: 1608150
ROCI (R&D-adjusted, %): -21.555892308867193
FCF margin (%): -62.10855949895616
Rule of 40 score: -62.10855949895616
Financial ratios for CLRO — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -27000
Operating income: -854000
Net income: -13736000
Capital expenditures: 0
Operating cash flow: -754000
Depreciation & amortization: -187000
Net tangible assets: 3461000
Owner earnings: -13923000
Return on net tangible assets (%): -402.2825772898006
Buffett classification: The Gruesome
Stock price: 5.81
Shares outstanding: 2675412
Book value: 3461000
P/B ratio: 4.4912290436290085
Market cap (USD): 15544143.719999999
Debt to equity: 0.16353655013002022
Current ratio: 2.2921887496667557
Quick ratio: 2.187683284457478
Free cash flow (dilution-adjusted): -776000
Buyback yield (%): 0
Retained earnings: -31958000
Inventory turnover: 0.06887755102040816
Capitalized R&D asset: 910530
ROCI (R&D-adjusted, %): -19.70590408185112
Rosenberg metric: 0.15011037527593818
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CLRO — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -248000
Operating income: -1136000
Net income: -4942000
Capital expenditures: 0
Operating cash flow: -11232000
Depreciation & amortization: 52000
Net tangible assets: -714000
Owner earnings: -4890000
Buffett classification: The Gruesome
Stock price: 5.09
Shares outstanding: 2675412
Book value: -714000
Market cap (USD): 13617847.08
Debt to equity: -0.7184873949579832
Current ratio: 1.140551445864156
Quick ratio: 0.9031607262945528
Free cash flow (dilution-adjusted): -11212000
Buyback yield (%): 0
Retained earnings: -36143000
Inventory turnover: 0.7025495750708215
Capitalized R&D asset: 448470
ROCI (R&D-adjusted, %): -126.06408720556618
Rule of 40 score: 0
Financial ratios for CLRO — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -328000
Operating income: -4396000
Net income: -26084000
Capital expenditures: 0
Operating cash flow: -14554000
Depreciation & amortization: 256000
Net tangible assets: -714000
Owner earnings: -25828000
Buffett classification: The Gruesome
Stock price: 5.09
Shares outstanding: 2675412
Book value: -714000
Market cap (USD): 13617847.08
Debt to equity: -0.7184873949579832
Current ratio: 1.140551445864156
Quick ratio: 0.9031607262945528
Free cash flow (dilution-adjusted): -14633000
Buyback yield (%): 0
Retained earnings: -36143000
Inventory turnover: 0.9291784702549575
Capitalized R&D asset: 3421760
ROCI (R&D-adjusted, %): -158.70841364020006
Rosenberg metric: -0.040618369202788725
Rule of 40 score: 0
Financial ratios for DIS.TO — quarterly report dated 2025-12-31
Total revenue: 18964233576.642334
Gross profit: 6797080291.970802
Operating income: 2828467153.2846713
Net income: 1813138686.1313868
Capital expenditures: 2199270072.9927006
Operating cash flow: 536496350.3649635
Depreciation & amortization: 960583941.6058394
Net tangible assets: 17740145985.40146
Owner earnings: 574452554.7445254
Return on net tangible assets (%): 3.238150098749177
Capex to operating income (%): 77.75483870967741
Buffett classification: The Gruesome
Stock price: 9.335766423357663
P/E ratio: 19.936743582217016
Shares outstanding: 20431714330
Book value: 83217518248.17517
P/B ratio: 2.2921341158576594
Market cap (USD): 190745712613.64963
Debt to equity: 0.4090940986597432
Current ratio: 0.6693476318141197
Quick ratio: 0.6126531041370972
Effective tax rate (%): 32.73761169780666
Interest coverage ratio: 8.747178329571106
COGS to revenue (%): 64.15842346330011
SG&A to revenue (%): 15.861591162772795
Free cash flow (dilution-adjusted): -1905109489.0510948
Buyback yield (%): 0.7783511946367455
Retained earnings: 43915328467.15328
Inventory turnover: 7.727862772369031
Receivables turnover: 1.7258535937292414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.362185524527106
FCF margin (%): -10.04580270197452
Revenue growth (%): 17.344572077692494
Rule of 40 score: 7.298769375717974
Financial ratios for DPP.L — annual report dated 2021-12-31
Total revenue: 7374367.654320988
Gross profit: 1342827.4074074074
Operating income: -933754.3209876544
Net income: -1076659.5061728396
Capital expenditures: 155429.38271604938
Operating cash flow: 102427.40740740742
Depreciation & amortization: 1201896.0493827162
Net tangible assets: -234550.86419753087
Owner earnings: -30192.83950617275
Buffett classification: The Gruesome
Stock price: 0.0008108108108108108
Shares outstanding: 943987674
Book value: 4016358.765432099
P/B ratio: 0.19056948247226774
Market cap (USD): 765395.4113513513
Debt to equity: 0.9550385697308409
Current ratio: 0.5998034982898575
Quick ratio: 0.51250597321282
Interest coverage ratio: -2.2651355743273394
COGS to revenue (%): 81.7906094413318
SG&A to revenue (%): 14.40148925596098
Free cash flow (dilution-adjusted): -181602.96296296298
Buyback yield (%): 0
Retained earnings: -4253830.864197531
Inventory turnover: 36.57405472093044
Receivables turnover: 82.41062948563355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.885825474422436
FCF margin (%): -2.462624206925095
Rule of 40 score: -2.462624206925095
Financial ratios for DPP.L — annual report dated 2022-12-31
Total revenue: 8149337.442922374
Gross profit: 2162394.97716895
Operating income: -597815.5251141553
Net income: -995421.2328767123
Capital expenditures: 207723.74429223745
Operating cash flow: 44515.98173515982
Depreciation & amortization: 990002.2831050229
Net tangible assets: 108892.23744292237
Owner earnings: -213142.69406392693
Return on net tangible assets (%): -195.73727114905608
Buffett classification: The Gruesome
Stock price: 0.000963855421686747
Shares outstanding: 943987674
Book value: 3830919.4063926945
P/B ratio: 0.23750633753141767
Market cap (USD): 909867.6375903615
Debt to equity: 0.9109972587264153
Current ratio: 0.9017298615617971
Quick ratio: 0.7825270424759949
Interest coverage ratio: -2.080019065019661
COGS to revenue (%): 73.46538915201052
SG&A to revenue (%): 15.934623141338383
Free cash flow (dilution-adjusted): -231772.1461187215
Buyback yield (%): 0
Retained earnings: -5435641.095890411
Inventory turnover: 26.700479579680486
Receivables turnover: 13.127415089829167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.813177033068632
FCF margin (%): -2.844061222670482
Revenue growth (%): 10.508965987711436
Rule of 40 score: 7.664904765040954
Financial ratios for DPP.L — annual report dated 2023-12-31
Total revenue: 11383414.030612245
Gross profit: 2939833.9285714286
Operating income: -531505.612244898
Net income: -1270926.275510204
Capital expenditures: 355535.20408163266
Operating cash flow: 503888.2653061225
Depreciation & amortization: 1347836.9897959183
Net tangible assets: -984498.2142857143
Owner earnings: -278624.48979591834
Buffett classification: The Gruesome
Stock price: 0.0013924050632911392
Shares outstanding: 943987674
Book value: 3002220.4081632653
P/B ratio: 0.4378136972848616
Market cap (USD): 1314413.2169620253
Debt to equity: 1.4066763001261653
Current ratio: 0.394781860023776
Quick ratio: 0.33473284938169406
Interest coverage ratio: -1.8834886859707123
COGS to revenue (%): 74.17440918281953
SG&A to revenue (%): 0.0951370731983561
Free cash flow (dilution-adjusted): 12763.010204081642
Buyback yield (%): 0
Retained earnings: -7261871.9387755105
Inventory turnover: 32.004689674111155
Receivables turnover: 39.55496371859172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.357531420701804
FCF margin (%): 0.1121193533834348
Revenue growth (%): 39.68514753918599
Rule of 40 score: 39.797266892569425
Financial ratios for DPP.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4010210.218978102
Buffett classification: The Gruesome
Stock price: 0.001375
Shares outstanding: 943987674
Book value: 7636612.165450121
P/B ratio: 0.16996843935880218
Market cap (USD): 1297983.0517499999
Debt to equity: 0.2650316970914479
Current ratio: 1.5081660930437082
Quick ratio: 1.3900463353056767
Buyback yield (%): 0
Retained earnings: -6956779.075425791
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DPP.L — annual report dated 2024-12-31
Total revenue: 13051956.690997565
Gross profit: 3338450.8515815083
Operating income: -10241.84914841849
Net income: -124595.6204379562
Capital expenditures: 1160747.2019464718
Operating cash flow: 1291374.4525547444
Depreciation & amortization: 1133565.6934306568
Net tangible assets: 4010210.218978102
Owner earnings: -151777.1289537712
Return on net tangible assets (%): -3.7847673978659317
Buffett classification: The Gruesome
Stock price: 0.001375
Shares outstanding: 943987674
Book value: 7636612.165450121
P/B ratio: 0.16996843935880218
Market cap (USD): 1297983.0517499999
Debt to equity: 0.2650316970914479
Current ratio: 1.5081660930437082
Quick ratio: 1.3900463353056767
Interest coverage ratio: -0.04764394824292143
COGS to revenue (%): 74.4218362762101
SG&A to revenue (%): 0.7079752489125345
Free cash flow (dilution-adjusted): -26640.875912408752
Buyback yield (%): 0
Retained earnings: -6956779.075425791
Inventory turnover: 33.114608995127675
Receivables turnover: 34.35757184094852
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.11314730322539161
FCF margin (%): -0.20411403855472482
Revenue growth (%): 14.657664703210123
Rule of 40 score: 14.453550664655399
Financial ratios for DPP.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2573410.8033240996
Buffett classification: The Gruesome
Stock price: 0.0015068493150684932
Shares outstanding: 943987674
Book value: 9473728.254847646
P/B ratio: 0.15014650428379586
Market cap (USD): 1422447.1800000002
Debt to equity: 0.23938800986276115
Current ratio: 0.7734052640984519
Quick ratio: 0.6677534376173618
Buyback yield (%): 0
Retained earnings: -7988118.836565097
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRVN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 33.62
Shares outstanding: 164955964
Market cap (USD): 5545819509.679999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRVN — annual report dated 2022-12-31
Total revenue: 2033194000
Gross profit: 967511000
Operating income: 330709000
Net income: 43188000
Capital expenditures: 333798000
Operating cash flow: 197176000
Depreciation & amortization: 147156000
Net tangible assets: -1390030000
Owner earnings: -143454000
Capex to operating income (%): 100.93405380561158
Buffett classification: The Gruesome
Stock price: 27.31
P/E ratio: 104.31016432434936
Shares outstanding: 164955964
Book value: 1653569000
P/B ratio: 2.7243782248215824
Market cap (USD): 4504947376.84
Debt to equity: 2.36807051898046
Current ratio: 1.1305691526617572
Quick ratio: 0.9880336671824114
Effective tax rate (%): 36.82616330114135
Interest coverage ratio: 2.8985152853737204
COGS to revenue (%): 52.41423100796088
SG&A to revenue (%): 24.08260107004054
Free cash flow (dilution-adjusted): -259612000
Buyback yield (%): 0
Retained earnings: 84795000
Inventory turnover: 14.792934480843975
Receivables turnover: 10.42861466021758
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.516892207497564
FCF margin (%): -12.768678247132344
Rule of 40 score: -12.768678247132344
Financial ratios for DRVN — annual report dated 2023-12-31
Total revenue: 1710040000
Gross profit: 808522000
Operating income: 238996000
Net income: -798931000
Capital expenditures: 194658000
Operating cash flow: 228568000
Depreciation & amortization: 177534000
Net tangible assets: -1289269000
Owner earnings: -816055000
Capex to operating income (%): 81.44822507489665
Buffett classification: The Gruesome
Stock price: 14.26
Shares outstanding: 164955964
Book value: 906723000
P/B ratio: 2.594256511238824
Market cap (USD): 2352272046.64
Debt to equity: 4.715887873143176
Current ratio: 1.9222154333082846
Quick ratio: 1.7275117225815664
Interest coverage ratio: 1.4899907107811048
COGS to revenue (%): 52.71911768145774
SG&A to revenue (%): 28.82663563425417
Free cash flow (dilution-adjusted): -388198000
Buyback yield (%): 2.123733947838111
Retained earnings: -710087000
Inventory turnover: 10.839331016820767
Receivables turnover: 10.228307224844038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.3583483005895545
FCF margin (%): -22.701106406867673
Revenue growth (%): -15.893908795717476
Rule of 40 score: -38.595015202585145
Financial ratios for DRVN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.27
Shares outstanding: 164955964
Market cap (USD): 2353921606.2799997
Buyback yield (%): 8.496459672506611e-05
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRVN — quarterly report dated 2024-12-31
Total revenue: 564117000
Gross profit: 251597000
Operating income: 13086000
Net income: -306638000
Capital expenditures: 33427000
Operating cash flow: 32939000
Depreciation & amortization: 53727000
Net tangible assets: -1296554000
Owner earnings: -286338000
Capex to operating income (%): 255.44092923735292
Buffett classification: The Gruesome
Stock price: 16.14
Shares outstanding: 164955964
Book value: 543770000
P/B ratio: 4.8961679735182155
Market cap (USD): 2662389258.96
Debt to equity: 5.760566048145356
Current ratio: 1.3544460339318423
Quick ratio: 1.2455089553502592
Interest coverage ratio: 0.34693390598902407
COGS to revenue (%): 55.399854994619915
SG&A to revenue (%): 34.26540948065738
Free cash flow (dilution-adjusted): -48756000
Buyback yield (%): 0
Retained earnings: -1093370000
Inventory turnover: 6.392440017181779
Receivables turnover: 3.261753464894275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.272453978367329
FCF margin (%): -8.642887911550263
Rule of 40 score: -8.642887911550263
Financial ratios for DRVN — annual report dated 2024-12-31
Total revenue: 1752476000
Gross profit: 903798000
Operating income: 256357000
Net income: -297453000
Capital expenditures: 51371000
Operating cash flow: 243954000
Depreciation & amortization: 192234000
Net tangible assets: -1296554000
Owner earnings: -156590000
Capex to operating income (%): 20.03885206957485
Buffett classification: The Great
Stock price: 16.14
Shares outstanding: 164955964
Book value: 543770000
P/B ratio: 4.8961679735182155
Market cap (USD): 2662389258.96
Debt to equity: 5.760566048145356
Current ratio: 1.3544460339318423
Quick ratio: 1.2455089553502592
Effective tax rate (%): 97.82409436894751
Interest coverage ratio: 1.6329407418259645
COGS to revenue (%): 48.427367906892876
SG&A to revenue (%): 32.437077597639
Free cash flow (dilution-adjusted): -96777000
Buyback yield (%): 0
Retained earnings: -1093370000
Inventory turnover: 17.359283274356194
Receivables turnover: 10.132906232473157
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.337420490013248
FCF margin (%): -5.5223010186730095
Revenue growth (%): 2.481579378260158
Rule of 40 score: -3.0407216404128516
Financial ratios for DRVN — quarterly report dated 2025-03-31
Total revenue: 447612000
Gross profit: 225052000
Operating income: 54757000
Net income: 9926000
Capital expenditures: 8696000
Operating cash flow: 76334000
Depreciation & amortization: 37625000
Net tangible assets: -1432472000
Owner earnings: 38855000
Return on net tangible assets (%): -2.712443943057875
Capex to operating income (%): 15.881074565808936
Buffett classification: The Great
Stock price: 17.14
P/E ratio: 71.21058893209752
Shares outstanding: 164955964
Book value: 643243000
P/B ratio: 4.395454319689448
Market cap (USD): 2827345222.96
Debt to equity: 4.904034711609765
Current ratio: 1.4681220014607288
Quick ratio: 1.3285458751907913
Effective tax rate (%): 28.76278873536547
Interest coverage ratio: 1.5098715049909006
COGS to revenue (%): 49.72163391508717
SG&A to revenue (%): 33.50759139611985
Free cash flow (dilution-adjusted): -3740000
Buyback yield (%): 0
Retained earnings: -997077000
Inventory turnover: 3.4868163374014944
Receivables turnover: 2.0903359578581635
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1303282487106099
FCF margin (%): -0.8355450702840853
Revenue growth (%): -20.65263057131765
Rule of 40 score: -21.488175641601735
Financial ratios for DRVN — quarterly report dated 2025-06-30
Total revenue: 550988000
Gross profit: 283173000
Operating income: 38112000
Net income: 47564000
Capital expenditures: 14114000
Operating cash flow: 79193000
Depreciation & amortization: 41792000
Net tangible assets: -1361107000
Owner earnings: 75242000
Return on net tangible assets (%): -5.528000370286833
Capex to operating income (%): 37.03295549958018
Buffett classification: The Good
Stock price: 17.56
P/E ratio: 15.224890294340256
Shares outstanding: 164955964
Book value: 743395000
P/B ratio: 3.896484006268538
Market cap (USD): 2896626727.8399997
Debt to equity: 3.9041438266332165
Current ratio: 1.1143238770614057
Quick ratio: 1.0127246709162914
Effective tax rate (%): 37.68337730870712
Interest coverage ratio: 1.215344877068784
COGS to revenue (%): 48.606321734774625
SG&A to revenue (%): 38.142028501528166
Free cash flow (dilution-adjusted): 8567000
Buyback yield (%): 0
Retained earnings: -949513000
Inventory turnover: 3.9874190426561453
Receivables turnover: 1.6767282697674135
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0521096853056893
FCF margin (%): 1.554843299672588
Revenue growth (%): 23.095001921306846
Rule of 40 score: 24.649845220979433
Financial ratios for DRVN — quarterly report dated 2025-09-30
Total revenue: 535684000
Gross profit: 269825000
Operating income: 61936000
Net income: 60862000
Capital expenditures: 12469000
Operating cash flow: 79218000
Depreciation & amortization: 40882000
Net tangible assets: -1307685000
Owner earnings: 89275000
Return on net tangible assets (%): -6.82694991530835
Capex to operating income (%): 20.1320718160682
Buffett classification: The Great
Stock price: 16.11
P/E ratio: 10.915844780158391
Shares outstanding: 164955964
Book value: 793490000
P/B ratio: 3.3490536491197114
Market cap (USD): 2657440580.04
Debt to equity: 3.472620953005079
Current ratio: 0.9027660349179508
Quick ratio: 0.8021794404981578
Effective tax rate (%): -55.248322832436294
Interest coverage ratio: 2.624073211032496
COGS to revenue (%): 49.62981907243823
SG&A to revenue (%): 32.306546396756296
Free cash flow (dilution-adjusted): 34265000
Buyback yield (%): 0
Retained earnings: -888651000
Inventory turnover: 4.0779047472965715
Receivables turnover: 2.6229061904785222
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7671855196699824
FCF margin (%): 6.396494948514422
Revenue growth (%): -2.777555954031667
Rule of 40 score: 3.6189389944827552
Financial ratios for DRVN — annual report dated 2025-12-31
Total revenue: 1862438000
Gross profit: 946164000
Operating income: 259237000
Net income: 140162000
Capital expenditures: 73099000
Operating cash flow: 330543000
Depreciation & amortization: 152128000
Net tangible assets: -1068649000
Owner earnings: 219191000
Return on net tangible assets (%): -20.511037768247572
Capex to operating income (%): 28.197749549639905
Buffett classification: The Good
Stock price: 14.82
P/E ratio: 17.441584641200897
Shares outstanding: 164955964
Book value: 767202000
P/B ratio: 3.1864455338750424
Market cap (USD): 2444647386.48
Debt to equity: 3.4684216151678435
Current ratio: 0.7451760592003108
Quick ratio: 0.6730150026108869
Effective tax rate (%): -10.770688830924843
Interest coverage ratio: 2.1388838468012077
COGS to revenue (%): 49.19755718042695
SG&A to revenue (%): 32.48800765448299
Free cash flow (dilution-adjusted): 75493000
Buyback yield (%): 0
Retained earnings: -953208000
Inventory turnover: 17.494491646778044
Receivables turnover: 10.276994217101487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.548877978097983
FCF margin (%): 4.053450369891507
Revenue growth (%): 6.274665102403684
Rule of 40 score: 10.328115472295192
Financial ratios for DRVN — quarterly report dated 2025-12-31
Total revenue: 259603000
Gross profit: 130372000
Operating income: 97924000
Net income: 26230000
Capital expenditures: 37820000
Operating cash flow: 95798000
Depreciation & amortization: 31829000
Net tangible assets: -1068649000
Owner earnings: 20239000
Return on net tangible assets (%): -1.8938865801586862
Capex to operating income (%): 38.621788325640296
Buffett classification: The Good
Stock price: 14.82
P/E ratio: 16.908379926131882
Shares outstanding: 164955964
Book value: 767202000
P/B ratio: 3.1864455338750424
Market cap (USD): 2444647386.48
Debt to equity: 3.4684216151678435
Current ratio: 0.7451760592003108
Quick ratio: 0.6730150026108869
Effective tax rate (%): -14.648357359739586
Interest coverage ratio: 3.296438429946812
COGS to revenue (%): 49.78024136855121
SG&A to revenue (%): 20.597990007819632
Free cash flow (dilution-adjusted): 36401000
Buyback yield (%): 0
Retained earnings: -953208000
Inventory turnover: 2.467417661097852
Receivables turnover: 1.432497903147486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8515077983747186
FCF margin (%): 14.021794817471292
Revenue growth (%): -51.5380336168338
Rule of 40 score: -37.51623879936251
Financial ratios for EFT — annual report dated 2021-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.21
Shares outstanding: 26578058
Market cap (USD): 244783914.18000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFT — annual report dated 2022-05-31
Total revenue: -12231793
Net income: -12839548
Capital expenditures: 0
Operating cash flow: 278279689
Net tangible assets: 385295481
Owner earnings: -12839548
Return on net tangible assets (%): -3.3323899794194576
Buffett classification: The Gruesome
Stock price: 8.46
Shares outstanding: 26578058
Book value: 385295481
P/B ratio: 0.583579049763109
Market cap (USD): 224850370.68000004
Debt to equity: 0.38152536753993227
Free cash flow (dilution-adjusted): 278279689
Buyback yield (%): 73.71763119567919
Retained earnings: -81830389
Receivables turnover: -2.098408839816918
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFT — annual report dated 2023-05-31
Total revenue: 15473852
Net income: 14923157
Capital expenditures: 0
Operating cash flow: 64907964
Net tangible assets: 369557340
Owner earnings: 14923157
Return on net tangible assets (%): 4.038116791294147
Buffett classification: The Gruesome
Stock price: 8.43
P/E ratio: 15.013782200374894
Shares outstanding: 26578058
Book value: 369557340
P/B ratio: 0.6062740600416704
Market cap (USD): 224053028.94
Debt to equity: 0.3193009236401583
COGS to revenue (%): 0
SG&A to revenue (%): 3.503697721808377
Free cash flow (dilution-adjusted): 64907964
Buyback yield (%): 0
Retained earnings: -97518160
Receivables turnover: 2.327082253985847
Capitalized R&D asset: 0
FCF margin (%): 419.4686882102789
Rule of 40 score: 419.4686882102789
Financial ratios for EFT — annual report dated 2024-05-31
Total revenue: 56132937
Net income: 55315772
Capital expenditures: 0
Operating cash flow: 83000416
Net tangible assets: 348989138
Owner earnings: 55315772
Return on net tangible assets (%): 15.850284715738058
Buffett classification: The Gruesome
Stock price: 11.25
P/E ratio: 5.405386957267812
Shares outstanding: 26578058
Book value: 348989138
P/B ratio: 0.8567692227143183
Market cap (USD): 299003152.5
Debt to equity: 0.32092689371896727
COGS to revenue (%): 0
SG&A to revenue (%): 1.4283004646630195
Free cash flow (dilution-adjusted): 83000416
Buyback yield (%): 12.407273866451959
Retained earnings: -81305976
Receivables turnover: 4.749421033309273
Capitalized R&D asset: 0
FCF margin (%): 147.8640178759932
Revenue growth (%): 262.75994497039267
Rule of 40 score: 410.6239628463859
Financial ratios for EFT — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 349065132
Buffett classification: The Gruesome
Stock price: 11.88
Shares outstanding: 26578058
Book value: 349065132
P/B ratio: 0.9045513289479742
Market cap (USD): 315747329.04
Debt to equity: 0.3466401794608348
Buyback yield (%): 0
Retained earnings: -84395994
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EFT — annual report dated 2025-05-31
Total revenue: 20359153
Net income: 19631892
Capital expenditures: 0
Operating cash flow: 14627792
Net tangible assets: 340391823
Owner earnings: 19631892
Return on net tangible assets (%): 5.767439366485604
Buffett classification: The Gruesome
Stock price: 11.27
P/E ratio: 15.257557124906759
Shares outstanding: 26578058
Book value: 340391823
P/B ratio: 0.8799703559859016
Market cap (USD): 299534713.65999997
Debt to equity: 0.3495971170846839
COGS to revenue (%): 0
SG&A to revenue (%): 3.532646962277851
Free cash flow (dilution-adjusted): 14627792
Buyback yield (%): 0
Retained earnings: -94840049
Receivables turnover: 1.9517426882577757
Capitalized R&D asset: 0
FCF margin (%): 71.84872573038771
Revenue growth (%): -63.730468975817175
Rule of 40 score: 8.118256754570538
Financial ratios for EFT — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 340391823
Buffett classification: The Gruesome
Stock price: 11.27
Shares outstanding: 26578058
Book value: 340391823
P/B ratio: 0.8799703559859016
Market cap (USD): 299534713.65999997
Debt to equity: 0.3495971170846839
Buyback yield (%): 0
Retained earnings: -94840049
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLR — annual report dated 2021-12-31
Capital expenditures: 145672000
Depreciation & amortization: 73200000
Net tangible assets: 1144000000
Buffett classification: The Gruesome
Stock price: 24.77
Shares outstanding: 139669896
Market cap (USD): 3459623323.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLR — annual report dated 2022-12-31
Total revenue: 13744000000
Gross profit: 355000000
Operating income: 113000000
Net income: 145000000
Capital expenditures: 75000000
Operating cash flow: 31000000
Depreciation & amortization: 73000000
Net tangible assets: 1580000000
Owner earnings: 143000000
Return on net tangible assets (%): 9.050632911392405
Capex to operating income (%): 66.3716814159292
Buffett classification: The Good
Stock price: 34.66
P/E ratio: 33.385921347310344
Shares outstanding: 139669896
Book value: 1996000000
P/B ratio: 2.4253299575951903
Market cap (USD): 4840958595.36
Debt to equity: 0.5661322645290581
Current ratio: 1.568407960199005
Quick ratio: 1.568407960199005
Effective tax rate (%): 70.08196721311475
Interest coverage ratio: 1.9152542372881356
COGS to revenue (%): 97.41705471478464
SG&A to revenue (%): 1.760768335273574
Free cash flow (dilution-adjusted): -63000000
Buyback yield (%): 0
Retained earnings: 896000000
Receivables turnover: 6.790513833992095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.129327056217114
FCF margin (%): -0.45838183934807913
Rule of 40 score: -0.45838183934807913
Financial ratios for FLR — annual report dated 2023-12-31
Total revenue: 15474000000
Gross profit: 477000000
Operating income: 259000000
Net income: 139000000
Capital expenditures: 106000000
Operating cash flow: 212000000
Depreciation & amortization: 74000000
Net tangible assets: 1734000000
Owner earnings: 107000000
Return on net tangible assets (%): 6.170703575547866
Capex to operating income (%): 40.92664092664093
Buffett classification: The Good
Stock price: 39.17
P/E ratio: 39.35877572892087
Shares outstanding: 139669896
Book value: 2052000000
P/B ratio: 2.666115899766082
Market cap (USD): 5470869826.320001
Debt to equity: 0.564327485380117
Current ratio: 1.6006955422067657
Quick ratio: 1.6006955422067657
Effective tax rate (%): 74.92063492063492
Interest coverage ratio: 4.316666666666666
COGS to revenue (%): 96.9174098487786
SG&A to revenue (%): 1.4088147860928009
Free cash flow (dilution-adjusted): 58000000
Buyback yield (%): 0
Retained earnings: 979000000
Receivables turnover: 7.271616541353383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.797900262467192
FCF margin (%): 0.37482228253845157
Revenue growth (%): 12.587310826542492
Rule of 40 score: 12.962133109080943
Financial ratios for FLR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.71
Shares outstanding: 139669896
Market cap (USD): 6663650738.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLR — quarterly report dated 2024-12-31
Net income: 1863000000
Capital expenditures: 0
Owner earnings: 1863000000
Buffett classification: The Gruesome
Stock price: 49.32
P/E ratio: 0.9243853020289855
Shares outstanding: 139669896
Market cap (USD): 6888519270.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0